Exploration of mRNA-modifying METTL3 oncogene as momentous prognostic biomarker responsible for colorectal cancer development
The study supports the potential of METTL3 as a prognostic biomarker in CRC and highlights its involvement in immune modulation and cancer progression. These findings lay the groundwork for future studies aimed at developing targeted therapies and improving patient outcomes.
Authors
- Roaa Mohammed Tahir Kassim (ORCID: https://orcid.org/0009-0006-3715-4451)
- Syeda Izma Makhdoom (ORCID: https://orcid.org/0000-0002-9978-1067)
- Fakhria A. Al‐Joufi
- J. Hamza (ORCID: https://orcid.org/0000-0001-9654-2979)
- Ayaz Ali Khan (ORCID: https://orcid.org/0000-0002-9274-2620)
- Tariq Aziz (ORCID: https://orcid.org/0000-0003-0905-8076)
- Nawal Al‐Hoshani (ORCID: https://orcid.org/0000-0003-1303-4798)
- Muhammad Saad Mughal (ORCID: https://orcid.org/0000-0001-7461-6826)
- Maher S. Alwethaynani
- Muhammad Naveed (ORCID: https://orcid.org/0000-0002-6935-8479)
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- University of Central Punjab (PK)
- University of Ioannina (GR)
- Umm al-Qura University (SA)
- Jouf University (SA)
- Shaqra University (SA)
- University of Malakand (PK)
Publication Details
- Journal
- Open Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/med-2025-1167
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Princess Nourah Bint Abdulrahman University